These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7871548)

  • 21. Determination of age and gender differences in biochemical processes affecting the disposition of 2-butoxyethanol and its metabolites in mice and rats to improve PBPK modeling.
    Corley RA; Grant DM; Farris E; Weitz KK; Soelberg JJ; Thrall KD; Poet TS
    Toxicol Lett; 2005 Mar; 156(1):127-61. PubMed ID: 15705493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic studies in Tg.AC and FVB mice administered [14C] benzene either by oral gavage or intradermal injection.
    Hoffmann MJ; Sinko PJ; Lee YH; Meeker RJ; Snyder R
    Toxicol Appl Pharmacol; 2001 Jul; 174(2):139-45. PubMed ID: 11446829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model.
    Clarke DO; Elswick BA; Welsch F; Conolly RB
    Toxicol Appl Pharmacol; 1993 Aug; 121(2):239-52. PubMed ID: 8346541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reassessing benzene cancer risks using internal doses.
    Cox LA; Ricci PF
    Risk Anal; 1992 Sep; 12(3):401-10. PubMed ID: 1410709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of dose on 2,3,7,8-TCDD tissue distribution, metabolism and elimination in CYP1A2 (-/-) knockout and C57BL/6N parental strains of mice.
    Hakk H; Diliberto JJ; Birnbaum LS
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):119-26. PubMed ID: 19695277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
    Fisher JW; Mahle D; Abbas R
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative metabolism of benzene and trans,trans-muconaldehyde to trans,trans-muconic acid in DBA/2N and C57BL/6 mice.
    Witz G; Maniara W; Mylavarapu V; Goldstein BD
    Biochem Pharmacol; 1990 Sep; 40(6):1275-80. PubMed ID: 2403381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of benzene metabolites in urine of mice by solid-phase extraction and high-performance liquid chromatography.
    Schad H; Schäfer F; Weber L; Seidel HJ
    J Chromatogr; 1992 Feb; 593(1-2):147-51. PubMed ID: 1639898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using urinary biomarkers to elucidate dose-related patterns of human benzene metabolism.
    Kim S; Vermeulen R; Waidyanatha S; Johnson BA; Lan Q; Rothman N; Smith MT; Zhang L; Li G; Shen M; Yin S; Rappaport SM
    Carcinogenesis; 2006 Apr; 27(4):772-81. PubMed ID: 16339183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicological and biochemical effects of repeated administration of benzene in mice.
    Longacre SL; Kocsis JJ; Witmer CM; Lee EW; Sammett D; Snyder R
    J Toxicol Environ Health; 1981 Feb; 7(2):223-37. PubMed ID: 7230271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
    Cox LA
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of age and dose on disposition and metabolism of salicylic acid in male Fischer 344 rats.
    McMahon TF; Diliberto JJ; Birnbaum LS
    Drug Metab Dispos; 1990; 18(4):494-503. PubMed ID: 1976074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of stable isotopically labeled benzene to evaluate environmental exposures.
    Weisel CP; Park S; Pyo H; Mohan K; Witz G
    J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):393-402. PubMed ID: 12973367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting age-appropriate pharmacokinetics of six volatile organic compounds in the rat utilizing physiologically based pharmacokinetic modeling.
    Rodriguez CE; Mahle DA; Gearhart JM; Mattie DR; Lipscomb JC; Cook RS; Barton HA
    Toxicol Sci; 2007 Jul; 98(1):43-56. PubMed ID: 17426107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-, route-, and sex-dependent urinary excretion of phenol metabolites in B6C3F1 mice.
    Kenyon EM; Seeley ME; Janszen D; Medinsky MA
    J Toxicol Environ Health; 1995 Feb; 44(2):219-33. PubMed ID: 7853423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interaction between benzene metabolites, phenol and hydroquinone, in B6C3F1 mice.
    Legathe A; Hoener BA; Tozer TN
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):131-8. PubMed ID: 8291054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of liquid chromatography-electrospray ionization-tandem mass spectrometry methods for determination of urinary metabolites of benzene in humans.
    Melikian AA; Meng M; O'Connor R; Hu P; Thompson SM
    Res Rep Health Eff Inst; 1999 Jun; (87):1-36: discussion 37-43. PubMed ID: 10500979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species differences in the metabolism of benzene.
    Henderson RF
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1173-5. PubMed ID: 9118889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PBPK models in risk assessment--A focus on chloroprene.
    DeWoskin RS
    Chem Biol Interact; 2007 Mar; 166(1-3):352-9. PubMed ID: 17324392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.